Reflexion Health logo

Reflexion Health Funding & Investors

RefleXion Medical, Inc. operates as a medical device company. The Company develops biologically-guided radiation therapy systems for treating solid tumors in the body. RefleXion Medical produces products by leveraging its positron emission tomography that allows tumors to continuously signal their location during treatment.

https://reflexion.com/

Total Amount Raised: $675,099,968

Reflexion Health Funding Rounds

  • Series Unknown

    $105,000,000

    Series Unknown Investors

    Johnson & Johnson Innovation – JJDC
    Ally Bridge Group
    Pictet
    Squarepoint Ops
    Catalio Capital Management
    Venrock
    Pfizer Venture Investments
    Hillenbrand Capital Partners, LLC.
    T. Rowe Price
    The Rise Fund
  • Debt Financing

    $125,000,000

  • Series Unknown

    $80,000,000

    Series Unknown Investors

    Ascension Health Ventures
    Johnson & Johnson Innovation – JJDC
    Ally Bridge Group
    Catalio Capital Management
    KCK
    PSP Investments
    Sixty Degree Capital
    Venrock
    Pfizer Venture Investments
    Hillenbrand Capital Partners, LLC.
    T. Rowe Price
    The Rise Fund
  • Series D

    $40,000,000

    Series D Investors

    Ally Bridge Group
  • Series D

    $100,000,000

    Series D Investors

    Johnson & Johnson Innovation – JJDC
    PSP Investments
    KCK
    Venrock
    Pfizer Venture Investments
    T. Rowe Price
    The Rise Fund
    Sofinnova Partners
  • Debt Financing

    $60,000,000

    Debt Financing Investors

    Oxford Finance
  • Series C

    $100,000,000

    Series C Investors

    KCK
    GT Healthcare Capital Partners
    Venrock
    Pfizer Venture Investments
    T. Rowe Price
    Johnson & Johnson Innovation
    The Rise Fund
    Sofinnova Partners
  • Series Unknown

    $105,000,000

    Series Unknown Investors

    Johnson & Johnson Innovation – JJDC
    Ally Bridge Group
    Pictet
    Squarepoint Ops
    Catalio Capital Management
    Venrock
    Pfizer Venture Investments
    Hillenbrand Capital Partners, LLC.
    T. Rowe Price
    The Rise Fund
  • Debt Financing

    $125,000,000

  • Series Unknown

    $80,000,000

    Series Unknown Investors

    Ascension Health Ventures
    Johnson & Johnson Innovation – JJDC
    Ally Bridge Group
    Catalio Capital Management
    KCK
    PSP Investments
    Sixty Degree Capital
    Venrock
    Pfizer Venture Investments
    Hillenbrand Capital Partners, LLC.
    T. Rowe Price
    The Rise Fund
  • Series D

    $40,000,000

    Series D Investors

    Ally Bridge Group
  • Series D

    $100,000,000

    Series D Investors

    Johnson & Johnson Innovation – JJDC
    PSP Investments
    KCK
    Venrock
    Pfizer Venture Investments
    T. Rowe Price
    The Rise Fund
    Sofinnova Partners
  • Debt Financing

    $60,000,000

    Debt Financing Investors

    Oxford Finance
  • Series C

    $100,000,000

    Series C Investors

    KCK
    GT Healthcare Capital Partners
    Venrock
    Pfizer Venture Investments
    T. Rowe Price
    Johnson & Johnson Innovation
    The Rise Fund
    Sofinnova Partners
  • Series B

    $52,000,000

    Series B Investors

    KCK
    Venrock
    Pfizer Venture Investments
    Johnson & Johnson Innovation
    Sofinnova Partners
  • Grant

    $1,500,000

    Grant Investors

    National Cancer Institute
  • Series A

    $11,600,000

    Series A Investors

    Venrock
    Pfizer Venture Investments
    Sofinnova Partners
  • Series B

    $52,000,000

    Series B Investors

    KCK
    Venrock
    Pfizer Venture Investments
    Johnson & Johnson Innovation
    Sofinnova Partners
  • Grant

    $1,500,000

    Grant Investors

    National Cancer Institute
  • Series A

    $11,600,000

    Series A Investors

    Venrock
    Pfizer Venture Investments
    Sofinnova Partners
Funding info provided by Diffbot.